THE Therapeutic Goods
Administration has approved the
Australian registration of Illumina’s
MiSeqDx system, which is an
instrument offering a variety of
assays and kits enabling clinical
laboratories to “create and deploy
next-generation sequencing-based
molecular diagnostic testing”.
The instrument is now cleared
for clinical use in the US, Canada,
Argentina, Europe, South Korea,
Singapore, Thailand and the
Philippines as well as Australia.The above article was sent to subscribers in Pharmacy Daily's issue from 27 May 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 May 16
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.